The report covers forecast and analysis for the cardiac arrhythmia monitoring devices market on a global and regional level. The study provides historic data from 2016 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the cardiac arrhythmia monitoring devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cardiac arrhythmia monitoring devices market on a global as well as regional level.
According to the report, global demand for cardiac arrhythmia monitoring devices market was valued at approximately USD 5,349.0 Million in 2018, and is expected to generate revenue of around USD 8,153.6 Million by end of 2025, growing at a CAGR of around 6.3% between 2019 and 2025.
In order to give the users of this report a comprehensive view on the cardiac arrhythmia monitoring devices market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product and services segment is benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the cardiac arrhythmia monitoring devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the cardiac arrhythmia monitoring devices market on global and regional basis.
Cardiac Arrhythmia can be described as a collection of conditions in which the heart beat is irregular. Cardiac Arrhythmia or irregular heartbeat can be divided as bradycardia (slow heartbeat), tachycardia (fast heartbeat), premature contraction (early heartbeat), and fibrillation (irregular heartbeat). Multiple factors can lead to arrhythmia like diabetes, alcohol abuse, heart disorders, and hypertension among other things. Cardiac monitoring is carried out to identify heart rhythm diseases.
Factors such as technological advancements in cardiac arrhythmia monitoring devices, increasing incidence of cardiovascular disorders, growing preference for low cost ECG devices, and healthcare cost containment will act as major driving factors in the growth of global cardiac arrhythmia monitoring devices market. Favorable government policies worldwide, increasing healthcare spending in developing regions will act as an opportunity for the market players in the cardiac arrhythmia monitoring devices market. Nonetheless, product recalls, high cost, and lack of awareness in low income countries will restrict the growth of global cardiac arrhythmia monitoring devices market.
The global cardiac arrhythmia monitoring devices market has been split into device, application, end user, and region. Based on device, cardiac arrhythmia monitoring devices market has been segmented into event recorder, electrocardiogram monitor, Holter monitor, implantable cardiac monitor, and mobile cardiac telemetry. The Holter monitor segment accounted for the highest market share in 2018 due to increasing adoption of such monitors amongst aging people. The application segment has been segmented into premature contraction, bradycardia, and tachycardia. The tachycardia segment accounted for the highest market share in 2018 due to rise in the occurrence of heart ailments such as flutter and atrial fibrillation. The end user segment has been segmented into diagnostic centers, hospitals and clinics, homecare settings, and ASCs.
North America will be the leading region during the forecast period. Presence of prominent market players, FDA approvals, and rapid acceptance of new technologies will boost the market growth in this region. Europe will be the second largest market. The major reasons are rise in awareness regarding use of cardiac monitoring devices, high prevalence of cardiovascular disoders, and favorable reimbursement scenario. Asia Pacific will propagate at speedy rate over the forecast period due to fast technological updation in the healthcare division and growing cases of cardiovascular disorders. Latin America market will develop at a significant rate during the forecast period. The Africa and Middle Eastern countries are likely to experience perceptible growth in the estimated time-frame.
The report also includes detailed profiles of key players such as Aurora Resurgence, GE Healthcare, Applied Cardiac Systems, Biotronik, AliveCor, Biotricity, BioTelemetry, Koninklijke Philips N.V., iRhythm Technologies, St. Jude Medical (Abbott Laboratories), Medtronic plc, Spacelabs Healthcare, and Nihon Kohden Corporation among others.
This report segments the Global Cardiac Arrhythmia Monitoring Devices Market as follows:
Global Cardiac Arrhythmia Monitoring Devices Market: By Device
Global Cardiac Arrhythmia Monitoring Devices Market: By End User
Global Cardiac Arrhythmia Monitoring Devices Market: By End User
Global Cardiac Arrhythmia Monitoring Devices Market: By Region
According to the report, global demand for cardiac arrhythmia monitoring devices market was valued at approximately USD 5,349.0 Million in 2018, and is expected to generate revenue of around USD 8,153.6 Million by end of 2025, growing at a CAGR of around 6.3% between 2019 and 2025.
In order to give the users of this report a comprehensive view on the cardiac arrhythmia monitoring devices market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product and services segment is benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the cardiac arrhythmia monitoring devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the cardiac arrhythmia monitoring devices market on global and regional basis.
Cardiac Arrhythmia can be described as a collection of conditions in which the heart beat is irregular. Cardiac Arrhythmia or irregular heartbeat can be divided as bradycardia (slow heartbeat), tachycardia (fast heartbeat), premature contraction (early heartbeat), and fibrillation (irregular heartbeat). Multiple factors can lead to arrhythmia like diabetes, alcohol abuse, heart disorders, and hypertension among other things. Cardiac monitoring is carried out to identify heart rhythm diseases.
Factors such as technological advancements in cardiac arrhythmia monitoring devices, increasing incidence of cardiovascular disorders, growing preference for low cost ECG devices, and healthcare cost containment will act as major driving factors in the growth of global cardiac arrhythmia monitoring devices market. Favorable government policies worldwide, increasing healthcare spending in developing regions will act as an opportunity for the market players in the cardiac arrhythmia monitoring devices market. Nonetheless, product recalls, high cost, and lack of awareness in low income countries will restrict the growth of global cardiac arrhythmia monitoring devices market.
The global cardiac arrhythmia monitoring devices market has been split into device, application, end user, and region. Based on device, cardiac arrhythmia monitoring devices market has been segmented into event recorder, electrocardiogram monitor, Holter monitor, implantable cardiac monitor, and mobile cardiac telemetry. The Holter monitor segment accounted for the highest market share in 2018 due to increasing adoption of such monitors amongst aging people. The application segment has been segmented into premature contraction, bradycardia, and tachycardia. The tachycardia segment accounted for the highest market share in 2018 due to rise in the occurrence of heart ailments such as flutter and atrial fibrillation. The end user segment has been segmented into diagnostic centers, hospitals and clinics, homecare settings, and ASCs.
North America will be the leading region during the forecast period. Presence of prominent market players, FDA approvals, and rapid acceptance of new technologies will boost the market growth in this region. Europe will be the second largest market. The major reasons are rise in awareness regarding use of cardiac monitoring devices, high prevalence of cardiovascular disoders, and favorable reimbursement scenario. Asia Pacific will propagate at speedy rate over the forecast period due to fast technological updation in the healthcare division and growing cases of cardiovascular disorders. Latin America market will develop at a significant rate during the forecast period. The Africa and Middle Eastern countries are likely to experience perceptible growth in the estimated time-frame.
The report also includes detailed profiles of key players such as Aurora Resurgence, GE Healthcare, Applied Cardiac Systems, Biotronik, AliveCor, Biotricity, BioTelemetry, Koninklijke Philips N.V., iRhythm Technologies, St. Jude Medical (Abbott Laboratories), Medtronic plc, Spacelabs Healthcare, and Nihon Kohden Corporation among others.
This report segments the Global Cardiac Arrhythmia Monitoring Devices Market as follows:
Global Cardiac Arrhythmia Monitoring Devices Market: By Device
- Event Recorder
- Electrocardiogram Monitor
- Holter Monitor
- Implantable Cardiac Monitor
- Mobile Cardiac Telemetry
Global Cardiac Arrhythmia Monitoring Devices Market: By End User
- Premature Contraction
- Bradycardia
- Tachycardia
Global Cardiac Arrhythmia Monitoring Devices Market: By End User
- Diagnostic Centers
- Hospitals and Clinics
- Homecare Settings
- ASCs
Global Cardiac Arrhythmia Monitoring Devices Market: By Region
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table of Contents
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Cardiac Arrhythmia Monitoring Market, 2016–2025 (USD Million)
- 2.2. Cardiac Arrhythmia Monitoring Market: Snapshot
- Chapter 3. Cardiac Arrhythmia Monitoring – Industry Analysis
- 3.1. Cardiac Arrhythmia Monitoring: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Technulogical advancements in cardiac arrhythmia monitoring devices
- 3.2.2. Increasing incidence of cardiovascular disorders
- 3.3. Restraints
- 3.3.1. Device recalls
- 3.3.2. High cost
- 3.4. Opportunity
- 3.4.1. Favorable government pulicies worldwide
- 3.4.2. Increasing healthcare spending in developing regions
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis By Device
- 3.6.2. Market attractiveness analysis By Application
- 3.6.3. Market attractiveness analysis By End User
- 3.6.4. Market attractiveness analysis by Region
- Chapter 4. Cardiac Arrhythmia Monitoring– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Cardiac Arrhythmia Monitoring: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New product launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Cardiac Arrhythmia Monitoring –Device Analysis
- 5.1. Global Cardiac Arrhythmia Monitoring overview: By Device
- 5.1.1. Global Cardiac Arrhythmia Monitoring share, By Device,2018 and 2025
- 5.2. Event Recorder
- 5.2.1. Global Cardiac Arrhythmia Monitoring by Event Recorder, 2016–2025 (USD Million)
- 5.3. Electrocardiogram Monitor
- 5.3.1. Global Cardiac Arrhythmia Monitoring by Electrocardiogram Monitor, 2016–2025 (USD Million)
- 5.4. Hulter Monitor
- 5.4.1. Global Cardiac Arrhythmia Monitoring by Hulter Monitor, 2016–2025 (USD Million)
- 5.5. Implantable Cardiac Monitor
- 5.5.1. Global Cardiac Arrhythmia Monitoring by Implantable Cardiac Monitor, 2016–2025 (USD Million)
- 5.5.2. Mobile Cardiac Telemetry
- 5.5.3. Global Cardiac Arrhythmia Monitoring by Mobile Cardiac Telemetry, 2016–2025 (USD Million)
- 5.1. Global Cardiac Arrhythmia Monitoring overview: By Device
- Chapter 6. Global Cardiac Arrhythmia Monitoring –Application Analysis
- 6.1. Global Cardiac Arrhythmia Monitoring overview: By Application
- 6.1.1. Global Cardiac Arrhythmia Monitoring share, By Application, 2018 and 2025
- 6.2. Premature Contraction
- 6.2.1. Global Cardiac Arrhythmia Monitoring By Premature Contraction, 2016–2025 (USD Million)
- 6.3. Bradycardia
- 6.3.1. Global Cardiac Arrhythmia Monitoring By Bradycardia, 2016–2025 (USD Million)
- 6.4. Tachycardia
- 6.4.1. Global Cardiac Arrhythmia Monitoring By Tachycardia, 2016–2025 (USD Million)
- 6.1. Global Cardiac Arrhythmia Monitoring overview: By Application
- Chapter 7. Global Cardiac Arrhythmia Monitoring –End User Analysis
- 7.1. Global Cardiac Arrhythmia Monitoring overview: By End User
- 7.1.1. Global Cardiac Arrhythmia Monitoring share, By End User, 2018 and 2025
- 7.2. Diagnostic Centers
- 7.2.1. Global Cardiac Arrhythmia Monitoring by Diagnostic Centers, 2016–2025 (USD Million)
- 7.3. Hospitals and Clinics
- 7.3.1. Global Cardiac Arrhythmia Monitoring by Hospitals and Clinics, 2016–2025 (USD Million)
- 7.4. Homecare Settings
- 7.4.1. Global Cardiac Arrhythmia Monitoring by Homecare Settings, 2016–2025 (USD Million)
- 7.5. ASCs
- 7.5.1. Global Cardiac Arrhythmia Monitoring by ASCs, 2016–2025 (USD Million)
- 7.1. Global Cardiac Arrhythmia Monitoring overview: By End User
- Chapter 8. Global Cardiac Arrhythmia Monitoring - Regional Analysis
- 8.1. Global Cardiac Arrhythmia Monitoring overview: by Region
- 8.1.1. Global Cardiac Arrhythmia Monitoring share, by Region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America Cardiac Arrhythmia Monitoring, 2016–2025 (USD Million)
- 8.2.2. North America Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.2.3. North America Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.2.4. North America Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.2.5. U.S.
- 8.2.5.1. U.S. Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.2.5.2. U.S. Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.2.5.3. U.S. Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.2.6.2. Rest of North America Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.2.6.3. Rest of North America Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Cardiac Arrhythmia Monitoring, 2016–2025 (USD Million)
- 8.3.2. Europe Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.3.3. Europe Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.3.4. Europe Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.3.5. UK
- 8.3.5.1. UK Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.3.5.2. UK Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.3.5.3. UK Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.3.6. France
- 8.3.6.1. France Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.3.6.2. France Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.3.6.3. France Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.3.7. Germany
- 8.3.7.1. Germany Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.3.7.2. Germany Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.3.7.3. Germany Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.3.8.2. Rest of Europe Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.3.8.3. Rest of Europe Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Cardiac Arrhythmia Monitoring, 2016–2025 (USD Million)
- 8.4.2. Asia Pacific Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.4.3. Asia Pacific Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.4.4. Asia Pacific Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.4.5. China
- 8.4.5.1. China Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.4.5.2. China Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.4.5.3. China Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.4.6. Japan
- 8.4.6.1. Japan Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.4.6.2. Japan Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.4.6.3. Japan Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.4.7. India
- 8.4.7.1. India Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.4.7.2. India Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.4.7.3. India Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.4.8.2. Rest of Asia Pacific Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.4.8.3. Rest of Asia Pacific Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Cardiac Arrhythmia Monitoring, 2016–2025 (USD Million)
- 8.5.2. Latin America Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.5.3. Latin America Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.5.4. Latin America Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.5.5. Brazil
- 8.5.5.1. Brazil Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.5.5.2. Brazil Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.5.5.3. Brazil Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.5.6.2. Rest of Latin America Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.5.6.3. Rest of Latin America Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Cardiac Arrhythmia Monitoring, 2016–2025 (USD Million)
- 8.6.2. The Middle East and Africa Cardiac Arrhythmia Monitoring revenue, By Device,2016–2025 (USD Million)
- 8.6.3. The Middle East and Africa Cardiac Arrhythmia Monitoring revenue, By Application, 2016–2025 (USD Million)
- 8.6.4. The Middle East and Africa Cardiac Arrhythmia Monitoring revenue, By End User, 2016–2025 (USD Million)
- 8.1. Global Cardiac Arrhythmia Monitoring overview: by Region
- Chapter 9. Company Profiles
- 9.1. Aurora Resurgence
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Device portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. GE Healthcare
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Device portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Applied Cardiac Systems
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Device portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Biotronik
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Device portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. AliveCor
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Device portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Development
- 9.6. Biotricity S
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Device portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Development
- 9.7. BioTelemetry
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Device portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Development
- 9.8. Koninklijke Philips N.V.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Device portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Development
- 9.9. iRhythm Technulogies
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Device portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Development
- 9.10. St. Jude Medical (Abbott Laboratories)
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Device portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Development
- 9.11. Medtronic plc.
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Device portfolio
- 9.11.4. Business Strategy
- 9.11.5. Recent Development
- 9.12. Spacelabs Healthcare
- 9.12.1. Overview
- 9.12.2. Financials
- 9.12.3. Device portfolio
- 9.12.4. Business Strategy
- 9.12.5. Recent Development
- 9.13. Nihon Kohden Corporation
- 9.13.1. Overview
- 9.13.2. Financials
- 9.13.3. Device portfolio
- 9.13.4. Business Strategy
- 9.13.5. Recent Development
- 9.1. Aurora Resurgence
